Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort

[1] Paun BC(2010)Postoperative complications following surgery for rectal cancer Ann Surg 251 807-818

[2] Cassie S(2014)Low anterior resection syndrome and quality of life: an international multicenter study Dis Colon Rectum 57 585-591

[3] MacLean AR(2017)Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection-a matched-controlled study Dis Colon Rectum 60 1032-1040

[4] Dixon E(2004)Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 240 711-717

[5] Buie WD(2018)Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study Lancet. 391 2537-2545

[6] Juul T(2011)Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer J Clin Oncol 29 4633-4640

[7] Ahlberg M(2016)Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis Lancet Oncol 17 174-183

[8] Biondo S(2017)A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis Lancet Gastroenterol Hepatol 2 501-513

[9] Espin E(2016)KRAS and combined KRAS/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy Ann Surg Oncol 23 2548-2555

[10] Jimenez LM(2014)Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer J Gastrointest Cancer 45 34-39

[1] Paun BC(2010)Postoperative complications following surgery for rectal cancer Ann Surg 251 807-818

[2] Cassie S(2014)Low anterior resection syndrome and quality of life: an international multicenter study Dis Colon Rectum 57 585-591

[3] MacLean AR(2017)Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection-a matched-controlled study Dis Colon Rectum 60 1032-1040

[4] Dixon E(2004)Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 240 711-717

[5] Buie WD(2018)Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study Lancet. 391 2537-2545

[6] Juul T(2011)Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer J Clin Oncol 29 4633-4640

[7] Ahlberg M(2016)Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis Lancet Oncol 17 174-183

[8] Biondo S(2017)A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis Lancet Gastroenterol Hepatol 2 501-513

[9] Espin E(2016)KRAS and combined KRAS/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy Ann Surg Oncol 23 2548-2555

[10] Jimenez LM(2014)Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer J Gastrointest Cancer 45 34-39